These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20513082)

  • 1. Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears.
    Cuzick J; Ambroisine L; Cadman L; Austin J; Ho L; Terry G; Liddle S; Dina R; McCarthy J; Buckley H; Bergeron C; Soutter WP; Lyons D; Szarewski A
    J Med Virol; 2010 Jul; 82(7):1186-91. PubMed ID: 20513082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
    Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?
    Twiggs LB; Hopkins M
    J Low Genit Tract Dis; 2011 Jul; 15(3):224-30. PubMed ID: 21716051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.
    Carcopino X; Henry M; Benmoura D; Fallabregues AS; Richet H; Boubli L; Tamalet C
    J Med Virol; 2006 Aug; 78(8):1131-40. PubMed ID: 16789021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.
    Poljak M; Oštrbenk A
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):43-7. PubMed ID: 23836358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Abbott RealTime High Risk HPV test: comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test.
    Poljak M; Kovanda A; Kocjan BJ; Seme K; Jancar N; Vrtacnik-Bokal E
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):94-103. PubMed ID: 19784522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.
    Chung HS; Hahm C; Lee M
    J Virol Methods; 2014 Sep; 205():57-60. PubMed ID: 24814874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific human papillomavirus DNA detected in atypical glandular cell Pap tests.
    Mulhem E; Amin M; Copeland J; Sharma J; Hunter S
    Acta Cytol; 2012; 56(2):155-9. PubMed ID: 22378077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection.
    Halfon P; Benmoura D; Agostini A; Khiri H; Penaranda G; Martineau A; Blanc B
    J Clin Virol; 2010 Aug; 48(4):246-50. PubMed ID: 20541966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new multiplex real-time polymerase chain reaction assay for the detection of human papillomavirus infections in a referral population.
    Jentschke M; Soergel P; Lange V; Kocjan B; Doerk T; Luyten A; Petry KU; Poljak M; Hillemanns P
    Int J Gynecol Cancer; 2012 Jul; 22(6):1050-6. PubMed ID: 22740006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.
    Stoler MH; Wright TC; Sharma A; Apple R; Gutekunst K; Wright TL;
    Am J Clin Pathol; 2011 Mar; 135(3):468-75. PubMed ID: 21350104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens.
    Kocjan BJ; Seme K; Poljak M
    J Virol Methods; 2011 Jul; 175(1):117-9. PubMed ID: 21513740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the Abbott RealTime High Risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens.
    Kaliterna V; Židovec Lepej S; Vince A
    J Med Microbiol; 2009 Dec; 58(Pt 12):1662-1663. PubMed ID: 19661205
    [No Abstract]   [Full Text] [Related]  

  • 18. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria.
    Todorova I; Ganchev G; Shikova E
    J Clin Pathol; 2010 Dec; 63(12):1121-3. PubMed ID: 20943820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.
    Moussavou-Boundzanga P; Koumakpayi IH; Labouba I; Leroy EM; Belembaogo E; Berthet N
    Virol J; 2017 Dec; 14(1):241. PubMed ID: 29268766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.
    Stevens MP; Garland SM; Rudland E; Tan J; Quinn MA; Tabrizi SN
    J Clin Microbiol; 2007 Jul; 45(7):2130-7. PubMed ID: 17494721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.